Reunion Neuroscience Reports Fiscal Fourth Quarter and Full Year 2023 Financial Results and Provides a Corporate Update Jun 29, 2023 07:30AM
Reunion Neuroscience (REUN) Announces $13.1 Million Take-Private Transaction with MPM BioImpact Jun 1, 2023 07:31AM
Reunion Neuroscience Announces US$13.1 Million Take-Private Transaction with MPM BioImpact Jun 1, 2023 07:30AM
Reunion Neuroscience Announces Presentation at 2023 Bloom Burton & Co. Healthcare Investor Conference Apr 25, 2023 07:35AM
Reunion Neuroscience (REUN) Receives Nasdaq Non-compliance Notice Apr 25, 2023 07:30AM


Apr 25, 2023 07:30AM Reunion Neuroscience Receives NASDAQ Notification Regarding Minimum Bid Price Deficiency
Apr 3, 2023 07:31AM Reunion Neuroscience (REUN) Appoints Dr. Fred Grossman to Board of Directors
Apr 3, 2023 07:30AM Reunion Neuroscience Appoints Dr. Fred Grossman to Board of Directors
Mar 27, 2023 07:30AM Reunion Neuroscience Abstract Accepted for Poster Presentation at 2023 ASCP Annual Meeting
Mar 14, 2023 05:22AM Reunion Neuroscience (REUN) Files Lawsuit Against Mindset Pharma
Mar 13, 2023 06:52PM Reunion Neuroscience Files Lawsuit Against Mindset Pharma
Mar 7, 2023 07:30AM Reunion Neuroscience to Participate in the Oppenheimer Annual Healthcare Conference
Feb 14, 2023 07:30AM Reunion Neuroscience Provides Business Update and Reports Fiscal Third Quarter 2023 Financial Results
Feb 2, 2023 07:30AM Reunion Neuroscience Schedules Fiscal Third Quarter 2023 Conference Call for Tuesday, February 14, 2023, at 8:30 A.M. ET
Jan 18, 2023 07:31AM Reunion Neuroscience (REUN) Appoints Robert Alexander as Chief Medical Officer
Jan 18, 2023 07:30AM Reunion Neuroscience Appoints Robert Alexander as Chief Medical Officer
Nov 20, 2022 05:47PM Reunion Neuroscience (REUN) Announces $10M At-The-Market Equity Facility
Nov 18, 2022 05:05PM Reunion Neuroscience Puts in Place At-The-Market Equity Facility
Nov 7, 2022 07:30AM Reunion Neuroscience Schedules Fiscal Second Quarter 2023 Conference Call for Monday, November 14, 2022, at 8:30 A.M. ET
Oct 31, 2022 07:30AM Reunion Neuroscience to Present at Upcoming November Conferences
Oct 24, 2022 07:30AM Reunion Neuroscience Appoints Chief Financial Officer and Vice President, Medical Affairs
Oct 12, 2022 07:30AM Reunion Neuroscience CEO to Participate on Panel at 2022 Horizons Perspectives on Psychedelics Conference
Oct 7, 2022 05:30PM Reunion Neuroscience Inc. Announces Executive Changes
Oct 3, 2022 07:30AM Reunion Neuroscience to Participate in the Cantor Neurology & Psychiatry Conference
Sep 29, 2022 05:20PM Reunion Neuroscience Inc. Announces Results of Annual General and Special Shareholder Meeting
Sep 28, 2022 07:32AM Reunion Neuroscience (REUN) Appoints Greg Mayes as President and CEO
Sep 28, 2022 07:30AM Reunion Neuroscience Inc. Appoints Greg Mayes as President and Chief Executive Officer
Sep 8, 2022 08:00AM Reunion Neuroscience Inc. to Participate in Upcoming Investor Conferences
Aug 31, 2022 07:30AM Reunion Neuroscience Inc. Announces 2022 Annual General Meeting of Shareholders
Aug 16, 2022 12:46PM Reunion Neuroscience Inc. to Commence Trading on the Toronto Stock Exchange on August 17, 2022